multiple sclerosis	is a	demyelinating disease of the central nervous system
optic neuritis	is associated with	multiple sclerosis
relapsing-remitting multiple sclerosis	is a form of	multiple sclerosis
secondary progressive multiple sclerosis	is a form of	multiple sclerosis
primary progressive multiple sclerosis	is a form of	multiple sclerosis
gait disturbance	is a symptom of	multiple sclerosis
fatigue	is a symptom of	multiple sclerosis
numbness	is a symptom of	multiple sclerosis
spasticity	is a symptom of	multiple sclerosis
visual impairment	is a symptom of	multiple sclerosis
cognitive impairment	is a symptom of	multiple sclerosis
bladder dysfunction	is a symptom of	multiple sclerosis
depression	is a comorbidity of	multiple sclerosis
relapse	is a feature of	multiple sclerosis
disease-modifying therapy	is used for	multiple sclerosis
interferon beta	is a	disease-modifying therapy
glatiramer acetate	is a	disease-modifying therapy
fingolimod	is a	disease-modifying therapy
dimethyl fumarate	is a	disease-modifying therapy
teriflunomide	is a	disease-modifying therapy
natalizumab	is a	monoclonal antibody
ocrelizumab	is a	monoclonal antibody
alemtuzumab	is a	monoclonal antibody
cladribine	is a	disease-modifying therapy
siponimod	is a	disease-modifying therapy
plasma exchange	is used for	refractory relapse in multiple sclerosis
corticosteroids	are used for	acute MS relapse
MRI	is used for	diagnosis of multiple sclerosis
McDonald criteria	are used for	multiple sclerosis diagnosis
brain MRI	shows	demyelinating plaques
MRI	shows	demyelinating plaques
gadolinium-enhancing lesion	indicates	active inflammation in multiple sclerosis
oligoclonal bands	are found in	cerebrospinal fluid
cerebrospinal fluid	contains	oligoclonal bands
evoked potentials	are used for	diagnosis of multiple sclerosis
expanded disability status scale	is used for	disability assessment in multiple sclerosis
HLA-DRB1*15:01	is associated with	multiple sclerosis
vitamin D deficiency	is associated with	multiple sclerosis
age at onset	predicts	disability progression in multiple sclerosis
female sex	is a risk factor for	multiple sclerosis
smoking	increases	disability progression in multiple sclerosis
epstein-barr virus infection	is associated with	multiple sclerosis
pregnancy	reduces	relapse rate in multiple sclerosis
postpartum period	increases	relapse risk in multiple sclerosis
breastfeeding	reduces	postpartum relapse in multiple sclerosis
JC virus seropositivity	increases	PML risk with natalizumab
natalizumab	is associated with	progressive multifocal leukoencephalopathy
PML	is a risk of	natalizumab
liver injury	is a potential adverse event of	teriflunomide
injection-site reaction	is a potential adverse event of	glatiramer acetate
neutralizing antibodies	can develop with	interferon beta
neutralizing antibodies	reduce	efficacy of interferon beta
bone density loss	is associated with	corticosteroid therapy
flu-like symptoms	are associated with	interferon beta therapy
infection	is a potential adverse event of	alemtuzumab
thyroid dysfunction	is a potential adverse event of	alemtuzumab
thyroid autoimmunity	occurs with	alemtuzumab
PML	is a rare complication of	natalizumab
pseudobulbar affect	occurs in	multiple sclerosis
nystagmus	is a sign of	multiple sclerosis
ataxia	is a sign of	multiple sclerosis
hypoesthesia	is a symptom of	multiple sclerosis
demyelination	occurs in	multiple sclerosis
axonal loss	contributes to	disability in multiple sclerosis
myelin	is damaged in	multiple sclerosis
neurodegeneration	occurs with	multiple sclerosis
exercise	improves	fatigue in multiple sclerosis
physical therapy	improves	mobility in multiple sclerosis
occupational therapy	helps	daily living in multiple sclerosis
assistive devices	improve	mobility in multiple sclerosis
brain atrophy	correlates with	disability in multiple sclerosis
brain volume loss	correlates with	disability in multiple sclerosis
vision loss	is a complication of	multiple sclerosis
optic nerve atrophy	occurs with	multiple sclerosis
urinary incontinence	is a symptom of	multiple sclerosis
erectile dysfunction	is a symptom of	multiple sclerosis
dysarthria	is a symptom of	multiple sclerosis
cognitive reserve	influences	cognitive impairment in multiple sclerosis
EDSS score	predicts	disability progression in multiple sclerosis
MRI activity	predicts	relapse in multiple sclerosis
hospital admission	is associated with	relapse in multiple sclerosis
therapy adherence	predicts	relapse rate in multiple sclerosis
quality of life	relates to	physical therapy in multiple sclerosis
weight management	is advised for	multiple sclerosis
vitamin D supplementation	is used for	multiple sclerosis
disease-modifying therapy adherence	improves	relapse outcomes in multiple sclerosis
autoimmune disease	co-occurs with	multiple sclerosis
family history	increases	risk of multiple sclerosis
genetic predisposition	contributes to	multiple sclerosis
smoking cessation	improves	disease progression in multiple sclerosis
breath support training	improves	respiratory function in multiple sclerosis
assistive technology	supports	independence in multiple sclerosis
vision rehabilitation	aids	visual function in multiple sclerosis
cognitive rehabilitation	aids	cognitive function in multiple sclerosis
physical activity	reduces	fatigue in multiple sclerosis
neuroinflammation	contributes to	multiple sclerosis
immune dysregulation	underlies	multiple sclerosis
oligodendrocyte precursor cells	participate in	remyelination in multiple sclerosis
remyelination	is limited in	multiple sclerosis
neuroplasticity	can be enhanced by	rehabilitation in multiple sclerosis
